ACTINIUM PHARMACEUTICALS INC - COM (ATNM)

CUSIP: 00507W107

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM
Total 13F shares
3,200,203
Share change
+433,873
Total reported value
$5,660,000
Put/Call ratio
25%
Price per share
$1.77
Number of holders
26
Value change
+$751,225
Number of buys
15
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 00507W107?
CUSIP 00507W107 identifies ATNM - ACTINIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ACTINIUM PHARMACEUTICALS INC - COM (ATNM) as of Q2 2016

As of 30 Jun 2016, ACTINIUM PHARMACEUTICALS INC - COM (ATNM) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,200,203 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, GSA CAPITAL PARTNERS LLP, BlackRock Fund Advisors, Bank of New York Mellon Corp, D.A. DAVIDSON & CO., MORGAN STANLEY, and NORTHERN TRUST CORP. This page lists 26 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.